;PMID: 11901170
;source_file_2849.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..41] = [t:0..41]
;1)sentence:[e:47..156] = [t:47..156]
;2)section:[e:160..214] = [t:160..214]
;3)section:[e:218..291] = [t:218..291]
;4)sentence:[e:295..476] = [t:295..476]
;5)sentence:[e:477..592] = [t:477..592]
;6)sentence:[e:593..683] = [t:593..683]
;7)sentence:[e:684..827] = [t:684..827]
;8)sentence:[e:828..1020] = [t:828..1020]
;9)sentence:[e:1021..1181] = [t:1021..1181]
;10)sentence:[e:1182..1292] = [t:1182..1292]
;11)section:[e:1296..1341] = [t:1296..1341]

;section 0 Span:0..41
;J Cell Biol.  2002 Mar 18;156(6):1051-63.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..6] Cell) (NNP:[7..11] Biol) (.:[11..12] .)
        ('':[14..18] 2002) (NNP:[19..22] Mar) (CD:[23..29] 18;156)
        (-LRB-:[29..30] -LRB-) (CD:[30..31] 6) (-RRB-:[31..32] -RRB-)
        (::[32..33] :) (CD:[33..37] 1051) (CD:[37..40] -63) (.:[40..41] .)))

;sentence 1 Span:47..156
;Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons
; and enhances oxidative stress.
;[47..50]:gene-protein:"Tau"
;[101..104]:gene-protein:"APP"
(SENT
  (S-HLN
    (NP-SBJ (SYM:[47..50] Tau))
    (VP
      (VP (VBZ:[51..57] blocks)
        (NP
          (NP (NN:[58..65] traffic))
          (PP (IN:[66..68] of)
            (NP
              (NP
                (NP (NNS:[69..79] organelles))
                (,:[79..80] ,)
                (NP (NNS:[81..95] neurofilaments))
                (,:[95..96] ,) (CC:[97..100] and)
                (NP (NN:[101..104] APP) (NNS:[105..113] vesicles)))
              (PP-LOC (IN:[114..116] in)
                (NP (NNS:[117..124] neurons)))))))
      (CC:[126..129] and)
      (VP (VBZ:[130..138] enhances)
        (NP (JJ:[139..148] oxidative) (NN:[149..155] stress))))
    (.:[155..156] .)))

;section 2 Span:160..214
;Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM.
(SEC
  (FRAG (NNP:[160..166] Stamer) (NNP:[167..169] K,) (NNP:[170..175] Vogel)
        (NNP:[176..177] R) (,:[177..178] ,) (NNP:[179..184] Thies)
        (NNP:[185..186] E) (,:[186..187] ,) (NNP:[188..197] Mandelkow)
        (NNP:[198..199] E) (,:[199..200] ,) (NNP:[201..210] Mandelkow)
        (NN:[211..213] EM) (.:[213..214] .)))

;section 3 Span:218..291
;Max-Planck-Unit for Structural Molecular Biology, 22607 Hamburg, Germany.
(SEC
  (FRAG (JJ:[218..228] Max-Planck) (NN:[228..233] -Unit) (IN:[234..237] for)
        (NNP:[238..248] Structural) (NNP:[249..258] Molecular)
        (NNP:[259..266] Biology) (,:[266..267] ,) (CD:[268..273] 22607)
        (NNP:[274..281] Hamburg) (,:[281..282] ,) (NNP:[283..290] Germany)
        (.:[290..291] .)))

;sentence 4 Span:295..476
;We studied the effect of microtubule-associated tau protein on trafficking of
; vesicles and organelles in primary cortical neurons, retinal ganglion cells,
;and  neuroblastoma cells.
;[343..346]:gene-protein:"tau"
;[456..469]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (PRP:[295..297] We))
    (VP (VBD:[298..305] studied)
      (NP
        (NP (DT:[306..309] the) (NN:[310..316] effect))
        (PP (IN:[317..319] of)
          (NP
            (ADJP (NN:[320..331] microtubule) (HYPH:[331..332] -)
                  (VBN:[332..342] associated))
            (SYM:[343..346] tau) (NN:[347..354] protein)))
        (PP (IN:[355..357] on)
          (NP
            (NP (NN:[358..369] trafficking))
            (PP (IN:[370..372] of)
              (NP
                (NP
                  (NP (NNS:[374..382] vesicles))
                  (CC:[383..386] and)
                  (NP (NNS:[387..397] organelles)))
                (PP-LOC (IN:[398..400] in)
                  (NP
                    (NP (JJ:[401..408] primary) (JJ:[409..417] cortical)
                        (NNS:[418..425] neurons))
                    (,:[425..426] ,)
                    (NP (JJ:[427..434] retinal) (NN:[435..443] ganglion)
                        (NNS:[444..449] cells))
                    (,:[449..450] ,) (CC:[451..454] and)
                    (NP (NN:[456..469] neuroblastoma) (NNS:[470..475] cells))))))))))
    (.:[475..476] .)))

;sentence 5 Span:477..592
;Tau inhibits kinesin-dependent transport of peroxisomes,  neurofilaments, and
;Golgi-derived vesicles into neurites.
;[477..480]:gene-protein:"Tau"
;[490..497]:gene-protein:"kinesin"
(SENT
  (S
    (NP-SBJ (SYM:[477..480] Tau))
    (VP (VBZ:[481..489] inhibits)
      (NP
        (NP
          (ADJP (NN:[490..497] kinesin) (HYPH:[497..498] -)
                (JJ:[498..507] dependent))
          (NN:[508..517] transport))
        (PP (IN:[518..520] of)
          (NP
            (NP (NNS:[521..532] peroxisomes))
            (,:[532..533] ,)
            (NP (NNS:[535..549] neurofilaments))
            (,:[549..550] ,) (CC:[551..554] and)
            (NP
              (ADJP (NNP:[555..560] Golgi) (HYPH:[560..561] -)
                    (VBN:[561..568] derived))
              (NNS:[569..577] vesicles))))
        (PP (IN:[578..582] into)
          (NP (NNS:[583..591] neurites)))))
    (.:[591..592] .)))

;sentence 6 Span:593..683
;Loss of peroxisomes  makes cells vulnerable to oxidative stress and leads to
;degeneration.
(SENT
  (S
    (NP-SBJ
      (NP (NN:[593..597] Loss))
      (PP (IN:[598..600] of)
        (NP (NNS:[601..612] peroxisomes))))
    (VP
      (VP (VBZ:[614..619] makes)
        (S
          (NP-SBJ (NNS:[620..625] cells))
          (ADJP-PRD (JJ:[626..636] vulnerable)
            (PP (TO:[637..639] to)
              (NP (JJ:[640..649] oxidative) (NN:[650..656] stress))))))
      (CC:[657..660] and)
      (VP (VBZ:[661..666] leads)
        (PP (TO:[667..669] to)
          (NP (NN:[670..682] degeneration)))))
    (.:[682..683] .)))

;sentence 7 Span:684..827
;In  particular, tau inhibits transport of amyloid precursor protein (APP)
;into axons  and dendrites, causing its accumulation in the cell body.
;[700..703]:gene-protein:"tau"
;[726..751]:gene-protein:"amyloid precursor protein"
;[753..756]:gene-protein:"APP"
(SENT
  (S
    (PP (IN:[684..686] In)
      (NP (JJ:[688..698] particular)))
    (,:[698..699] ,)
    (NP-SBJ (SYM:[700..703] tau))
    (VP (VBZ:[704..712] inhibits)
      (NP
        (NP (NN:[713..722] transport))
        (PP (IN:[723..725] of)
          (NP
            (NP (JJ:[726..733] amyloid) (NN:[734..743] precursor)
                (NN:[744..751] protein))
            (NP (-LRB-:[752..753] -LRB-) (NN:[753..756] APP)
                (-RRB-:[756..757] -RRB-))))
        (PP (IN:[758..762] into)
          (NP
            (NP (NNS:[763..768] axons))
            (CC:[770..773] and)
            (NP (NNS:[774..783] dendrites)))))
      (,:[783..784] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[784..784] *))
        (VP (VBG:[785..792] causing)
          (NP
            (NP (PRP$:[793..796] its) (NN:[797..809] accumulation))
            (PP (IN:[810..812] in)
              (NP (DT:[813..816] the) (NN:[817..821] cell) (NN:[822..826] body)))))))
    (.:[826..827] .)))

;sentence 8 Span:828..1020
;APP tagged with yellow  fluorescent protein and transfected by adenovirus
;associates with vesicles  moving rapidly forward in the axon (approximately
;80%) and slowly back  (approximately 20%).
;[828..831]:gene-protein:"APP"
;[844..871]:gene-protein:"yellow  fluorescent protein"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[828..831] APP))
      (VP
        (VP (VBN:[832..838] tagged)
          (NP (-NONE-:[838..838] *))
          (PP (IN:[839..843] with)
            (NP (JJ:[844..850] yellow) (JJ:[852..863] fluorescent)
                (NN:[864..871] protein))))
        (CC:[872..875] and)
        (VP (VBN:[876..887] transfected)
          (NP (-NONE-:[887..887] *))
          (PP-MNR (IN:[888..890] by)
            (NP (NN:[891..901] adenovirus))))))
    (VP (VBZ:[902..912] associates)
      (PP-CLR (IN:[913..917] with)
        (NP
          (NP (NNS:[918..926] vesicles))
          (VP
            (VP (VBG:[928..934] moving)
              (ADVP=1 (RB:[935..942] rapidly))
              (ADVP-DIR=2 (RB:[943..950] forward))
              (PP-LOC (IN:[951..953] in)
                (NP (DT:[954..957] the) (NN:[958..962] axon)
                  (PRN (-LRB-:[963..964] -LRB-)
                    (NP
                      (QP (RB:[964..977] approximately) (CD:[978..980] 80))
                      (NN:[980..981] %))
                    (-RRB-:[981..982] -RRB-)))))
            (CC:[983..986] and)
            (VP
              (ADVP=1 (RB:[987..993] slowly))
              (ADVP-DIR=2 (RB:[994..998] back))
              (PRN (-LRB-:[1000..1001] -LRB-)
                (NP
                  (QP (RB:[1001..1014] approximately) (CD:[1015..1017] 20))
                  (NN:[1017..1018] %))
                (-RRB-:[1018..1019] -RRB-)))))))
    (.:[1019..1020] .)))

;sentence 9 Span:1021..1181
;Both movements are strongly inhibited by cotransfection  with fluorescently
;tagged tau (cyan fluorescent protein-tau) as seen by  two-color confocal
;microscopy.
;[1104..1107]:gene-protein:"tau"
;[1109..1133]:gene-protein:"cyan fluorescent protein"
;[1134..1137]:gene-protein:"tau"
(SENT
  (S
    (NP-SBJ-1 (DT:[1021..1025] Both) (NNS:[1026..1035] movements))
    (VP (VBP:[1036..1039] are)
      (ADVP (RB:[1040..1048] strongly))
      (VP (VBN:[1049..1058] inhibited)
        (NP-1 (-NONE-:[1058..1058] *))
        (PP (IN:[1059..1061] by)
          (NP-LGS
            (NP (NN:[1062..1076] cotransfection))
            (PP (IN:[1078..1082] with)
              (NP
                (ADJP (RB:[1083..1096] fluorescently) (VBN:[1097..1103] tagged))
                (SYM:[1104..1107] tau)
                (PRN (-LRB-:[1108..1109] -LRB-)
                  (NP
                     (NN:[1109..1113] cyan)
                    (NML (JJ:[1114..1125] fluorescent) (NN:[1126..1133] protein))
                    (HYPH:[1133..1134] -) (SYM:[1134..1137] tau))
                  (-RRB-:[1137..1138] -RRB-))))))
        (SBAR (IN:[1139..1141] as)
          (S
            (NP-SBJ-2 (-NONE-:[1141..1141] *))
            (VP (VBN:[1142..1146] seen)
              (NP-2 (-NONE-:[1146..1146] *))
              (PP (IN:[1147..1149] by)
                (NP
                  (NML (CD:[1151..1154] two) (HYPH:[1154..1155] -)
                       (NN:[1155..1160] color))
                  (JJ:[1161..1169] confocal) (NN:[1170..1180] microscopy))))))))
    (.:[1180..1181] .)))

;sentence 10 Span:1182..1292
;The data suggests a linkage between tau and APP  trafficking, which may be
;significant in Alzheimer's disease.
;[1218..1221]:gene-protein:"tau"
;[1226..1229]:gene-protein:"APP"
(SENT
  (S
    (NP-SBJ (DT:[1182..1185] The) (NN:[1186..1190] data))
    (VP (VBZ:[1191..1199] suggests)
      (NP
        (NP
          (NP (DT:[1200..1201] a) (NN:[1202..1209] linkage))
          (PP (IN:[1210..1217] between)
            (NP
              (NP (SYM:[1218..1221] tau))
              (CC:[1222..1225] and)
              (NP (NN:[1226..1229] APP) (NN:[1231..1242] trafficking)))))
        (,:[1242..1243] ,)
        (SBAR
          (WHNP-1 (WDT:[1244..1249] which))
          (S
            (NP-SBJ-1 (-NONE-:[1249..1249] *T*))
            (VP (MD:[1250..1253] may)
              (VP (VB:[1254..1256] be)
                (ADJP-PRD (JJ:[1257..1268] significant))
                (PP (IN:[1269..1271] in)
                  (NP
                    (NP (NNP:[1272..1281] Alzheimer) (POS:[1281..1283] 's))
                    (NN:[1284..1291] disease)))))))))
    (.:[1291..1292] .)))

;section 11 Span:1296..1341
;PMID: 11901170 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1296..1300] PMID) (::[1300..1301] :) (CD:[1302..1310] 11901170)
        (NN:[1311..1312] -LSB-) (NNP:[1312..1318] PubMed) (::[1319..1320] -)
        (NN:[1321..1328] indexed) (IN:[1329..1332] for)
        (NNP:[1333..1341] MEDLINE-RSB-)))
